Young age as a prognostic factor in cervical cancer: results of a population-based study

Am J Obstet Gynecol. 1999 Jun;180(6 Pt 1):1464-7. doi: 10.1016/s0002-9378(99)70038-4.

Abstract

Objective: Our goal was to use population-based data to determine the difference in 5-year survival in women diagnosed with cervical cancer between those aged 18-34 years and those aged 40-60 years.

Study design: The SEER (Surveillance, Epidemiology, and End Results) public-use database, 1973-1994, was used for this investigation. Only subjects with cervical carcinoma diagnosed between 1988 and 1990 were included. Subjects were stratified on age at diagnosis (<35 years or 40-60 years), clinical stage, histologic type, race-ethnicity, and grade.

Results: Two thousand cases of invasive cervical cancer were identified. The younger subgroup of patients was diagnosed with earlier-stage disease more frequently than the older group (P =.0001). When adjustments were made for non-cervical cancer causes of death, there was no difference in 5-year survival between the 2 cohorts. African American women had a poorer 5-year survival (P =.02)

Conclusion: There was no overall difference in survival between the 2 cohorts when appropriate adjustments were made for cause of death and for stage, histologic type, and grade of disease.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenocarcinoma / mortality
  • Adenocarcinoma / pathology
  • Adolescent
  • Adult
  • Age Factors*
  • Black People
  • Black or African American
  • Female
  • Hispanic or Latino
  • Humans
  • Middle Aged
  • Neoplasm Staging
  • Prognosis
  • Racial Groups
  • SEER Program
  • Survival Rate
  • Uterine Cervical Neoplasms / mortality*
  • Uterine Cervical Neoplasms / pathology